Trypsin ChymotrypsinThird Party Manufacturing in India

Trypsin Chymotrypsin works by breaking down cellular debris and fibrin clots at inflamed injury sites through specific proteolytic actions. It restores microcirculation, accelerates the clearance of inflammatory exudates, and reduces regional interstitial edema. Unlike traditional NSAIDs, it promotes physiological tissue repair mechanisms without blocking cyclooxygenase pathways or causing gastric mucosal damage. It is highly effective and well-tolerated for speeding up healing times and reducing physical swelling.

Therapeutic Uses

• Post-Traumatic Edema: Reduction of acute tissue swelling associated with accidental trauma or hematomas.
• Surgical Inflammation: Alleviation of post-operative edema in dental, orthopedic, or general surgical interventions.

Why Manufacturers Choose Trypsin Chymotrypsin

Trypsin Chymotrypsin third party manufacturing in India experiences exceptional market pull due to its widespread prescription as an adjunct to anti-inflammatory drugs. Our production facilities maintain rigorous temperature and humidity controls required to preserve the enzymatic activity of these proteins during processing. Celesta leverages WHO-GMP certified production environments to secure premium, enteric-coated tablets that prevent premature stomach degradation.